Extremely important negative changes in investment behavior have recently occurred for Gilead Sciences Inc (NASDAQ: GILD): negative upside/downside volume developed, and its shorter term price trend turned down.
Gilead Sciences Inc (NASDAQ: GILD). Important negative changes in fundamentals have recently occurred: significant quarterly sales deceleration occurred, and significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Gilead Sciences has a current Value Trend Rating of C (High Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Gilead Sciences has a slightly negative Appreciation Score of 34 but a very high Power Rating of 85, triggering the High Neutral Value Trend Rating.
Recent Price Action
Gilead Sciences Inc (NASDAQ: GILD) stock rose slightly by 0.2% on 1/17/25. The stock closed at $91.84. NORMAL trading volume accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 3.0% during the last week.
Be the first to comment